|
|
|
board of directors
|
Board of Directors Alice Jacobs, M.D.
Alice Jacobs, M.D. is the Founder, Chairman and CEO of IntelligentMDx, a molecular diagnostics company based in Cambridge, MA that develops and manufactures tests for rapid, precise, clinically impactful detection of infectious diseases. Dr. Jacobs founded IntelligentMDx after losing a patient during her medical training to a healthcare-associated infection to leverage discoveries made in life sciences to improve efficiency in healthcare delivery, increase the confidence of clinicians in treatment, and reduce the cost of care worldwide. Since founding the company, Dr. Jacobs has assembled a team of visionary leaders dedicated to her vision of integrating next-generation solutions into current health care practices. In 2004, Scientific American named Dr. Jacobs as one of the top 50 innovators in science and technology. Dr. Jacobs was selected by the World Economic Forum as a member of the Forum of Young Global Leaders in 2006. She serves as a member of the Whitehead Board of Associates. She holds a B.Sc. in Biological Sciences as well as a B.A. in Art History from Stanford University. Dr. Jacobs earned her M.D. from Harvard Medical School.
Rick Braddock has most recently served as Chairman – Executive Committee of MidOcean Partners, a private equity firm. He previously held numerous executive positions, including President and COO of Citicorp, Chairman of True North Communications, and Chairman and CEO of priceline.com Incorporated. He is also a Director of Marriott International, Cadbury Schweppes, plc, and Eastman Kodak Company
Charles Ellis is Founder and Director of the international strategy firm Greenwich Associates. He is a Director of Vanguard Funds and has served as chair and governor of the CFA Institute. Author of best-selling books on investment, he is an associate editor of The Journal of Portfolio Management and The Financial Analysts Journal. Mr. Ellis is also a Successor Trustee of Yale, a Director of the Whitehead Institute for Biomedical Research, and an Overseer of the Stern School of Business at New York University. A Yale graduate, he has a Harvard M.B.A. (with distinction) and a Ph.D. from NYU. He has taught investment management graduate courses at Harvard and Yale.
Leroy Hood is President and Director of the Institute for Systems Biology in Seattle, Washington. He began his professional career at the California Institute of Technology, where he and colleagues pioneered four instruments that form the technological basis of contemporary molecular biology. He created the multi-disciplinary Department of Molecular Biotechnology at the University of Washington. He has played a role in founding several biotechnology companies, including Amgen, Applied Biosystems, SyStemix, Darwin, and Rosetta. He received the Lasker Award in 1987 and is a member of the National Academy of Sciences, the American Philosophical Society, and the American Association of Arts and Sciences.
Eli Jacobs is a private investor who has invested in numerous early stage businesses in a range of sectors including medical technology and biotechnology. Mr. Jacobs received a B.A. from Yale University and an LL.B. from Yale Law School. Mr. Jacobs is the father of Alice Jacobs, Intelligent Medical Devices’ Chief Executive Officer and Chairman of the Board of Directors.
Suzanne Woolsey specializes in corporate and nonprofit governance. She has served the National Academies of Science, Engineering, and Medicine as Chief Operating Officer, Chief Communications Officer, and Executive Director for Behavioral and Social Sciences. Before that, she was a consulting partner with Coopers and Lybrand and Associate Director of the U.S. Office of Management and Budget. She serves on the boards of Fluor and VanKampen Mutual Funds, as well as on a range of nonprofit boards including Caltech, Institute for Defense Analyses, and German Marshall Fund of the U.S. She holds a B.A. from Stanford and an M.A. and Ph.D. from Harvard University in clinical and social psychology.
|
